These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 31726461

  • 1. Comparison of Imaging and Clinically Relevant Features of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Hepatocellular Carcinoma.
    Huang X, Li Y, Long L.
    Med Sci Monit; 2019 Nov 14; 25():8595-8601. PubMed ID: 31726461
    [Abstract] [Full Text] [Related]

  • 2. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X, Zhang BH, Qiu SJ, Ren ZG, Zhou J, Chen XH, Zhou Y, Fan J.
    Ann Surg Oncol; 2012 Sep 14; 19(9):2869-76. PubMed ID: 22451237
    [Abstract] [Full Text] [Related]

  • 3. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y, Wang L, Teng F, Zhang T, Zhao Y, Chen Z.
    Int J Med Sci; 2021 Sep 14; 18(1):187-198. PubMed ID: 33390787
    [Abstract] [Full Text] [Related]

  • 4. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH, Hwang S, Song GW, Ahn CS, Moon DB, Kim KH, Ha TY, Park GC, Hong SM, Kim WJ, Kang WH, Kim SH, Yu ES, Lee SG.
    Liver Transpl; 2017 Mar 14; 23(3):330-341. PubMed ID: 28027599
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.
    Tang D, Nagano H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M.
    J Gastrointest Surg; 2006 Mar 14; 10(7):987-98. PubMed ID: 16843869
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Yoon YI, Hwang S, Lee YJ, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Lee JW, Hong SM, Yu ES, Lee SG.
    J Gastrointest Surg; 2016 Feb 14; 20(2):411-20. PubMed ID: 26628072
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
    Lee SD, Park SJ, Han SS, Kim SH, Kim YK, Lee SA, Ko YH, Hong EK.
    Hepatobiliary Pancreat Dis Int; 2014 Dec 14; 13(6):594-601. PubMed ID: 25475861
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J, Fischer S, Menezes R, Hosseini-Nik H, Lewis S, Taouli B, Jhaveri K.
    Cancer Imaging; 2018 Feb 27; 18(1):8. PubMed ID: 29486800
    [Abstract] [Full Text] [Related]

  • 13. Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.
    Zhou YM, Yang JM, Wang B, Xu F, Tong Y, Li DQ.
    Hepatobiliary Pancreat Dis Int; 2007 Dec 27; 6(6):656-9. PubMed ID: 18086637
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Non-invasive imaging in the diagnosis of combined hepatocellular carcinoma and cholangiocarcinoma.
    Shen YT, Yue WW, Xu HX.
    Abdom Radiol (NY); 2023 Jun 27; 48(6):2019-2037. PubMed ID: 36961531
    [Abstract] [Full Text] [Related]

  • 17. The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study.
    He C, Mao Y, Wang J, Song Y, Huang X, Lin X, Li S.
    J Gastrointest Surg; 2018 Jul 27; 22(7):1239-1250. PubMed ID: 29667093
    [Abstract] [Full Text] [Related]

  • 18. The significance of the predominant component in combined hepatocellular-cholangiocarcinoma: MRI manifestation and prognostic value.
    Sheng R, Yang C, Zhang Y, Wang H, Zheng B, Han J, Sun W, Zeng M.
    Radiol Med; 2023 Sep 27; 128(9):1047-1060. PubMed ID: 37474663
    [Abstract] [Full Text] [Related]

  • 19. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
    Chi CT, Chau GY, Lee RC, Chen YY, Lei HJ, Hou MC, Chao Y, Huang YH.
    J Formos Med Assoc; 2020 Jan 27; 119(1 Pt 1):125-133. PubMed ID: 30876788
    [Abstract] [Full Text] [Related]

  • 20. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.
    Li R, Yang D, Tang CL, Cai P, Ma KS, Ding SY, Zhang XH, Guo DY, Yan XC.
    BMC Cancer; 2016 Feb 25; 16():158. PubMed ID: 26917546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.